Ebos Group Ltd
Company Profile
Business description
Ebos is the second-largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Contact
737 Bourke Street
Level 7
Docklands
MelbourneVIC3008
AUST: +61 399185555
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
30 June 2026
Employees
5,700
Ebos Group Ltd News & Analysis
stocks
5 overvalued stocks to avoid today
stocks
3 off-the-radar small caps
stocks
Small cap gems and how to find them
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% |
| CAC 40 | 8,145.97 | 11.32 | -0.14% |
| DAX 40 | 24,028.37 | 90.52 | -0.38% |
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% |
| FTSE 100 | 9,731.68 | 28.38 | -0.29% |
| HKSE | 25,906.65 | 376.04 | -1.43% |
| NASDAQ | 23,581.14 | 377.33 | -1.57% |
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% |
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% |
| S&P 500 | 6,822.34 | 68.25 | -0.99% |
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% |
| SSE Composite Index | 3,954.79 | 32.11 | -0.81% |